| pubmed-article:9601030 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9601030 | lifeskim:mentions | umls-concept:C0026882 | lld:lifeskim |
| pubmed-article:9601030 | lifeskim:mentions | umls-concept:C0010531 | lld:lifeskim |
| pubmed-article:9601030 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:9601030 | pubmed:issue | 21 | lld:pubmed |
| pubmed-article:9601030 | pubmed:dateCreated | 1998-6-12 | lld:pubmed |
| pubmed-article:9601030 | pubmed:abstractText | The conserved glycines in the glycine-rich loop (Leu-Gly50-Thr-Gly52-Ser-Phe-Gly55-Arg-Val) of the catalytic (C) subunit of cAMP-dependent protein kinase were each mutated to Ser (G50S, G52S, and G55S). The effects of these mutations were assessed here using both steady-state and pre-steady-state kinetic methods. While G50S and G52S reduced the apparent affinity for ATP by approximately 10-fold, substitution at Gly55 had no effect on nucleotide binding. In contrast to ATP, only mutation at position 50 interfered with ADP binding. These three mutations lowered the rate of phosphoryl transfer by 7-300-fold. The combined data indicate that G50 and G52 are the most critical residues in the loop for catalysis, with replacement at position 52 being the most extreme owing to a larger decrease in the rate of phosphoryl transfer (29 vs 1.6 s-1 in contrast to 500 s-1 for wild-type C). Surprisingly, all three mutations lowered the affinity for Kemptide by approximately 10-fold, although none of the loop glycines makes direct contact with the substrate. The inability to correlate the rate constant for net product release with the dissociation constant for ADP implies that other steps may limit the decomposition of the ternary product complex. The observations that G52S (a) selectively affects ATP binding and (b) significantly lowers the rate of phosphoryl transfer without making direct contact with either the nucleotide or the peptide imply that this residue serves a structural role in the loop, most likely by positioning the backbone amide of Ser53 for contacting the gamma-phosphate of ATP. Energy-minimized models of the mutant proteins are consistent with the observed kinetic consequences of each mutation. The models predict that only mutation of Gly52 will interfere with the observed hydrogen bonding between the backbone and ATP. | lld:pubmed |
| pubmed-article:9601030 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9601030 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9601030 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9601030 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9601030 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9601030 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9601030 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9601030 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9601030 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9601030 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9601030 | pubmed:month | May | lld:pubmed |
| pubmed-article:9601030 | pubmed:issn | 0006-2960 | lld:pubmed |
| pubmed-article:9601030 | pubmed:author | pubmed-author:AdamsJ AJA | lld:pubmed |
| pubmed-article:9601030 | pubmed:author | pubmed-author:TaylorS SSS | lld:pubmed |
| pubmed-article:9601030 | pubmed:author | pubmed-author:GrantB DBD | lld:pubmed |
| pubmed-article:9601030 | pubmed:author | pubmed-author:HemmerWW | lld:pubmed |
| pubmed-article:9601030 | pubmed:author | pubmed-author:TsigelnyII | lld:pubmed |
| pubmed-article:9601030 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9601030 | pubmed:day | 26 | lld:pubmed |
| pubmed-article:9601030 | pubmed:volume | 37 | lld:pubmed |
| pubmed-article:9601030 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9601030 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9601030 | pubmed:pagination | 7708-15 | lld:pubmed |
| pubmed-article:9601030 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:9601030 | pubmed:meshHeading | pubmed-meshheading:9601030-... | lld:pubmed |
| pubmed-article:9601030 | pubmed:meshHeading | pubmed-meshheading:9601030-... | lld:pubmed |
| pubmed-article:9601030 | pubmed:meshHeading | pubmed-meshheading:9601030-... | lld:pubmed |
| pubmed-article:9601030 | pubmed:meshHeading | pubmed-meshheading:9601030-... | lld:pubmed |
| pubmed-article:9601030 | pubmed:meshHeading | pubmed-meshheading:9601030-... | lld:pubmed |
| pubmed-article:9601030 | pubmed:meshHeading | pubmed-meshheading:9601030-... | lld:pubmed |
| pubmed-article:9601030 | pubmed:meshHeading | pubmed-meshheading:9601030-... | lld:pubmed |
| pubmed-article:9601030 | pubmed:meshHeading | pubmed-meshheading:9601030-... | lld:pubmed |
| pubmed-article:9601030 | pubmed:meshHeading | pubmed-meshheading:9601030-... | lld:pubmed |
| pubmed-article:9601030 | pubmed:meshHeading | pubmed-meshheading:9601030-... | lld:pubmed |
| pubmed-article:9601030 | pubmed:meshHeading | pubmed-meshheading:9601030-... | lld:pubmed |
| pubmed-article:9601030 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9601030 | pubmed:articleTitle | Kinetic analyses of mutations in the glycine-rich loop of cAMP-dependent protein kinase. | lld:pubmed |
| pubmed-article:9601030 | pubmed:affiliation | Howard Hughes Medical Institute, Department of Chemistry and Biochemistry, University of California at San Diego, La Jolla 92093-0654, USA. | lld:pubmed |
| pubmed-article:9601030 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9601030 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9601030 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9601030 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9601030 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9601030 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9601030 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9601030 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9601030 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9601030 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9601030 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9601030 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9601030 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9601030 | lld:pubmed |
